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This paper develops a semi-parametric Bayesian regression model
for estimating heterogeneous treatment effects from observational
data. Standard nonlinear regression models, which may work quite
well for prediction, can yield badly biased estimates of treatment ef-
fects when fit to data with strong confounding. Our Bayesian causal
forest model avoids this problem by directly incorporating an esti-
mate of the propensity function in the specification of the response
model, implicitly inducing a covariate-dependent prior on the regres-
sion function. This new parametrization also allows treatment hetero-
geneity to be regularized separately from the prognostic effect of con-
trol variables, making it possible to informatively “shrink to homo-
geneity”, in contrast to existing Bayesian non- and semi-parametric
approaches. We illustrate the benefits of this approach via the reanal-
ysis of an observational study assessing the causal effects of smoking
on medical expenditures as well as extensive simulation studies.
1. Introduction. The success of modern predictive modeling is founded on the understanding
that flexible predictive models must be carefully regularized in order to achieve good out-of-sample
performance (low generalization error). In a causal inference setting, regularization is less straight-
forward: In the presence of confounding, regularized models originally designed for prediction can
bias causal estimates towards some unknown function of high dimensional nuisance parameters
(Hahn et al., 2016). That is, despite offering excellent predictive performance, the causal conclu-
sions from a naively regularized nonlinear regression are likely to be substantially biased, leading
to high estimation error of the target parameter. A key finding in this paper is that this effect will
be especially pronounced in flexible models which allow for heterogeneous effects.
To mitigate these estimation problems we propose a flexible sum-of-regression-trees — a forest
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— to model a response variable as a function of a binary treatment indicator and a vector of control
variables. Our work departs from existing contributions — primarily Hill (2011) and later extensions
— in two important respects: First, we develop a novel prior for the response surface that depends
explicitly on estimates of the propensity score as an important 1-dimensional transformation of the
covariates (including the treatment assignment). Incorporating this transformation of the covariates
is not strictly necessary in response surface modeling, but we show that it can substantially improve
treatment effect estimation in the presence of moderate to strong confounding, especially when
that confounding is driven by targeted selection — individuals selecting into treatment based on
somewhat accurate predictions of the potential outcomes.
Second, we represent our regression as a sum of two functions: the first models the prognostic
impact of the control variables (the component of the conditional mean of the response that is
unrelated to the treatment effect), while the second represents the treatment effect directly, which
itself is a nonlinear function of the observed attributes (capturing possibly heterogeneous effects).
We represent each function as a forest. This approach allows the degree of shrinkage on the treat-
ment effect to be modulated directly and separately of the prognostic effect. In particular, under
this parametrization, standard regression tree priors shrink towards homogeneous effects.
In previous approaches, the prior distribution over treatment effects is induced indirectly, and
is therefore difficult to understand and control. Our approach interpolates between two extemes:
Modeling the conditional means of treated and control units entirely separately, or including treat-
ment assignment as “just another covariate” (see also Ku¨nzel et al. (2017) for detailed discussion of
the tradeoffs between these two approaches). The former precludes any borrowing or regularization
entirely, while the second can be rather difficult to understand using flexible models. Parametrizing
non- and semiparametric models this way is attractive regardless of the specific priors in use.
Comparisons on simulated data show that the new model — which we call the Bayesian causal
forest model — performs at least as well as existing approaches for estimating heterogenous treat-
ment effects across a range of plausible data generating processes. More importantly, it performs
dramatically better in many cases, especially those with strong confounding, targeted selection,
and relatively weak treatment effects, which we believe to be common in applied settings.
In section 7, we demonstrate how our flexible Bayesian model allows us to make rich inferences on
heterogeneous treatment effects, including estimates of average and conditional average treatment
effects at various levels, in a re-analysis of data from an observational study of the effect of smoking
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on medical expenditures.
As we have noted, the Bayesian causal forest model directly extends ideas from two earlier
papers: Hill (2011) and Hahn et al. (2016). Specifically, this paper studies the “regularization-
induced confounding” of Hahn et al. (2016) in the context of nonparametric Bayesian models as
utilized by Hill (2011). In terms of implementation, this paper builds explicitly on the work of
Chipman, George and McCulloch (2010); see also Gramacy and Lee (2008) and Murray (2017).
Other notable work on Bayesian treatment effect estimation includes Gustafson and Greenland
(2006),Zigler and Dominici (2014), Heckman, Lopes and Piatek (2014), Li and Tobias (2014), ?
and Taddy et al. (2016). A more complete discussion of how the new method relates to this earlier
literature, including non-Bayesian approaches, is deferred until Section 8.
2. Problem statement and notation. Let Y denote a scalar response variable and Z denote
a binary treatment indicator variable. Capital Roman letters denote random variables, while realized
values appear in lower case, that is, y and z. Let x denote a length d vector of observed control
variables. Throughout, we will consider an observed sample of size n independent observations
(Yi, Zi, xi), for i = 1, . . . n. When Y or Z (respectively, y or z) are without a subscript, they denote
length n column vectors; likewise, X will denote the n× d matrix of control variables.
We are interested in estimating various treatment effects. In particular, we are interested in
conditional average treatment effects (CATE) — the amount by which the response Yi would differ
between hypothetical worlds in which the treatment was set to Zi = 1 versus Zi = 0, averaged across
subpopulations defined by attributes x. This kind of counterfactual estimand can be formalized in
the potential outcomes framework (Imbens and Rubin (2015), chapter 1) by using Yi(0) and Yi(1)
to denote the outcomes we would have observed if treatment were set to zero or one, respectively.
We make the stable unit treatment value assumption (SUTVA) throughout (excluding interference
between units and multiple versions of treatment (Imbens and Rubin, 2015)). We observe the
potential outcome that corresponds to the realized treatment: Yi = ZiYi(1) + (1− Zi)Yi(0).
Throughout the paper we will assume that strong ignorability holds, which stipulates that
(1) Yi(0), Yi(1) ⊥ Zi | Xi.
and also that
(2) 0 < Pr(Zi = 1 | xi) < 1
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for all i = 1, . . . , n. The first condition assumes we have no unmeasured confounders, and the
second condition (overlap) is necessary to estimate treatment effects everywhere in covariate space.
Provided that these conditions hold, it follows that E(Yi(z) | xi) = E(Yi | xi, Zi = z) so our
estimand may be expressed as
(3) τ(xi) := E(Yi | xi, Zi = 1)− E(Yi | xi, Zi = 0).
For simplicity, we restrict attention to mean-zero additive error representations
(4) Yi = f(xi, Zi) + i, i ∼ N(0, σ2)
so that E(Yi | xi, Zi = zi) = f(xi, zi). In this context, (1) can be expressed equivalently as i ⊥ Zi |
xi. The treatment effect of setting zi = 1 versus zi = 0 can therefore be expressed as
τ(xi) := f(xi, 1)− f(xi, 0).
Our contribution in this paper is a careful study of prior specification for f . We propose new
prior distributions that improve estimation of the parameter of interest, namely τ . Previous work
(Hill, 2011) advocated using a Bayesian additive regression tree (BART) prior for f(xi, zi) directly.
We instead recommend expressing the response surface as
(5) E(Yi | xi, Zi = zi) = µ(xi, pˆi(xi)) + τ(xi)zi,
where the functions µ and τ are given independent BART priors and pˆi(xi) is an estimate of the
propensity score pi(xi) = Pr(Zi = 1 | xi). The following sections motivate this model specification
and provide additional context; further modeling details are given in Section 5.
3. Bayesian additive regression trees for heterogeneous treatment effect estimation.
Hill (2011) observed that under strong ignorability, treatment effect estimation reduces to response
surface estimation. That is, provided that a sufficiently rich collection of control variables are avail-
able (to ensure strong ignorability), treatment effect estimation can proceed “merely” by estimating
the conditional expectations E(Y | x, Z = 1) and E(Y | x, Z = 0). Noting its strong performance
in prediction tasks, Hill (2011) advocates the use of the Bayesian additive regression tree (BART)
model of Chipman, George and McCulloch (2010) for estimating these conditional expectations.
BART is particularly well-suited to detecting interactions and discontinuities, can be made invari-
ant to monotone transformations of the covariates, and typically requires little parameter tuning.
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Fig 1. (Left) An example binary tree, with internal nodes labelled by their splitting rules and terminal nodes labelled
with the corresponding parameters mlb. (Right) The corresponding partition of the sample space and the step function.
Chipman, George and McCulloch (2010) provide extensive evidence of BART’s excellent predic-
tive performance. BART has also been used successfully for applications in causal inference, for
example Green and Kern (2012), Hill et al. (2013), Kern et al. (2016), and Sivaganesan, Mu¨ller
and Huang (2017). It has subsequently been demonstrated to successfully infer heterogeneous and
average treatment effects in multiple independent simulation studies (Dorie et al., 2017; Wendling
et al., 2018), frequently outperforming competitors (and never lagging far behind).
Despite its excellent performance in practice, there are limited theoretical results about BART.
There have been recent developments on posterior consistency and rates of posterior concentration
for Bayesian tree models in prediction contexts (Linero and Yang, 2017; Rockova and van der Pas,
2017). These results require significant modifications to the BART prior, however, which we do
not further investigate here. To the extent that these results are informative or suggestive about
BART’s impressive performance in prediction, however, we expect those insights to carry over to
the treatment effect models presented here.
3.1. Specifying the BART prior. The BART prior expresses an unknown function f(x) as a sum
of many piecewise constant binary regression trees. (In this section, we suppress z in the notation;
implicitly z may be considered as a coordinate of x.) Each tree Tl, 1 ≤ l ≤ L, consists of a set of
internal decision nodes which define a partition of the covariate space (say A1, . . . ,AB(l)), as well
as a set of terminal nodes or leaves corresponding to each element of the partition. Further, each
element of the partition Ab is associated a parameter value, mlb. Taken together the partition and
the leaf parameters define a piecewise constant function: gl(x) = mlb if x ∈ Ab; see Figure 1.
Individual regression trees are then additively combined into a single regression forest: f(x) =
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∑L
l=1 gl(x). Each of the functions gl are constrained by their prior to be “weak learners” in the
sense that the prior favors small trees and leaf parameters that are near zero. Each tree follows
(independently) the prior described in Chipman, George and McCulloch (1998): the probability
that a node at depth h splits is given by η(1 + h)−β, η ∈ (0, 1), β ∈ [0,∞).
A variable to split on, as well as a cut-point to split at, are then selected uniformly at random
from the available splitting rules. Large, deep trees are given extremely low prior probability by
taking η = 0.95 and β = 2 as in Chipman, George and McCulloch (2010). The leaf parameters are
assigned independent priors mlb ∼ N(0, σ2m) where σm = σ0/
√
L. The induced marginal prior for
f(x) is centered at zero and puts approximately 95% of the prior mass within ±2σ0 (pointwise),
and σ0 can be used to calibrate the plausible range of the regression function. Full details of the
BART prior and its implementation are given by Chipman, George and McCulloch (2010).
In our context we are concerned with the impact that the prior over f(x, z) has on estimating
τ(x) = f(x, 1) − f(x, 0). The choice of BART as a prior over f has particular implications for the
induced prior on τ that are difficult to understand: In particular, the induced prior will vary with
the dimension of x and the degree of dependence with z. In Section 5 we propose an alternative
parameterization that mitigates this problem. But first, the next section develops a more general
framework for investigating the influence of prior specification and regularization on treatment
effect estimates.
4. The central role of the propensity score in regularized causal modeling. In this
section we explore the joint impacts of regularization and confounding on estimation of heteroge-
neous treatment effects. We find that including an estimate of the propensity score as a covariate
reduces the bias of regularized treatment effect estimates in finite samples. We recommend including
an estimated propensity score as a covariate as routine practice regardless of the particular models
or algorithms used to estimate treatment effects since regularization is necessary to estimate het-
erogeneous treatment effects non- or semiparamaterically or in high dimensions. To illustrate the
potential for biased estimation and motivate our fix, we introduce two key concepts: Regularization
induced confounding and targeted selection.
4.1. Regularization-induced confounding. Since treatment effects may be deduced from the con-
ditional expectation function f(xi, zi), a likelihood perspective suggests that the conditional distri-
bution of Y given x and Z is sufficient for estimating treatment effects. While this is true in terms
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of identification of treatment effects, the question of estimation with finite samples is more nu-
anced. In particular, many functions in the support of the prior will yield approximately equivalent
likelihood evaluations, but may imply substantially different treatment effects. This is particularly
true in a strong confounding-modest treatment effect regime, where the conditional expectation of
Y is largely determined by x rather than Z.
Accordingly, the posterior estimate of the treatment effect is apt to be substantially influenced by
the prior distribution over f for realistic sample sizes. This issue was explored by Hahn et al. (2016)
in the narrow context of linear regression with continuous treatment and homogenous treatment
effect; they call this phenomenon “regularization-induced confounding” (RIC). In the linear regres-
sion setting an exact expression for the bias on the treatment effect under standard regularization
priors is available in closed form.
Example: RIC in the linear model. Suppose the treatment effect is homogenous and response
and treatment model are both linear:
Yi = τZi + β
txi + εi,
Zi = γ
txi + νi;
(6)
where the error terms are mean zero Gaussian and a multivariate Gaussian prior is placed over all
regression coefficients. The Bayes estimator under squared error loss is the posterior mean, so we
examine the expression for the bias of τˆrr ≡ E(τ | Y, z,X). We begin from a standard expression for
the bias of the ridge estimator, as given, for example, in Giles and Rayner (1979). Write θ = (τ, βt)t,
X˜ =
(
z X
)
and let θ ∼ N(0,M−1). Then the bias of the Bayes estimator is
(7) bias(θˆrr) = −(M + X˜tX˜)−1Mθ
where the bias expectation is taken over Y , conditional on X and all model parameters.
Consider M =
0 0
0 Ip
, where Ip denotes a p-by-p identity matrix, which corresponds to a ridge
prior (with ridge parameter λ = 1 for simplicity) on the control variables and a non-informative
“flat” prior over the first element (τ , the treatment effect). Plugging this into the bias equation (7)
and noting that
(M + X˜tX˜)−1 =
 ztz ztX
Xtz XtX + Ip
−1
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we obtain
(8) bias(τˆrr) = −
(
(ztz)−1ztX
)
(I + Xt(X− Xˆz))−1β,
where Xˆz = z(z
tz)−1ztX. Notice that the leading term
(
(ztz)−1ztX
)
is a vector of regression coeffi-
cients from p univariate regressions predicting Xj given z. With completely randomized treatment
assignment these terms will tend to be near zero (and precisely zero in expectation over Z). This
ensures that the ridge estimate of τ is nearly unbiased, despite the fact that the middle matrix is
generally nonzero. However, in the presence of selection some of these regression coefficients will be
non-zero due to the correlation between Z and the covariates in X. As a result, the bias of τˆrr will
depend on the form of the design matrix and unknown nuisance parameters β.
The problem here is not simply that τˆrr is biased — after all, the insight behind regularization is
that some bias can actually improve our average estimation error. Rather, the problem is that the
degree of bias is not under the analyst’s control (as it depends on unknown nuisance parameters).
The use of a naive regularization prior in the presence of counfounding can unwittingly induce
extreme bias in estimation of the target parameter, even when all the confounders are measured
and the parametric model is correctly specified.
In more complicated nonparametric regression models with heterogeneous treatment effects a
closed-form expression of the bias is not generally available; see Yang, Cheng and Dunson (2015)
and Chernozhukov et al. (2016) for related results in a partially linear model where effects are
homogenous but the βtx term above is replaced by a nonlinear function. However, note that both
of these theoretical results consider asymptotic bias in semi- and non-parametric Bayesian and
frequentist inference; our attention here to the simple case of the linear model shows that the
phenomenon occurs in finite samples even in a parametric model. That said, the RIC phenomenon
can be reliably recreated in nonlinear, semiparametric settings. The easiest way to demonstrate this
is by considering scenarios where selection into treatment is based on expected outcomes under no
treatment, a situation we call targeted selection.
4.2. Targeted selection. Targeted selection refers to settings where treatment is assigned based
on a prediction of the outcome in the absence of treatment, given measured covariates. That is,
targeted selection asserts that treatment is being assigned, in part, based on an estimate of the
expected potential outcome µ(x) := E(Y (0) | x) and that the probability of treatment is generally
increasing or decreasing as a function of this estimate. We suspect this selection process is quite
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Fig 2. For any value of x˜, the propensity score pi(µ, x˜) is monotone in the prognostic function µ. Here, many realiza-
tions of this function are shown for different values of x˜.
common in practice; for example, in medical contexts where risk factors for adverse outcomes are
well-understood physicians are more likely to assign treatment to patients with worse expected
outcomes in its absence.
Targeted selection implies that there is a particular functional relationship between the propen-
sity score pi and the expected outcomes without treatment µ. In particular, suppose for simplicity
that there exists a change of variables x→ (µ(x), x˜) that takes the prognostic function µ(x) to the
first element of the covariate vector. Then targeted selection says that for every x˜, the propensity
function E(Z | x) = pi(µ, x˜) is (approximately) monotone in µ; see Figure 2 for a visual depiction.
If the relationship is strictly monotone so that pi is invertible in µ for any x˜, this in turn implies
that µ(x) is a function of pi(x).
Targeted selection and RIC in the linear model. To help understand how targeted selection leads
to RIC, it is helpful to again consider the linear model. There, one can describe RIC in terms of
three components: the coefficients defining the propensity function E(Z | x) = γx, the coefficients
defining the prognostic function, E(Y | Z = 0, x = x), and the strength of the selection as measured
9
Fig 3. Left panel: The propensity function, pi, shown for various values of x˜.The “shelf” at the line x1 = x2 is a
complex shape for many regression methods to represent. Right panel: the analogous plot for the prognostic function
µ. Note the similar shapes due to targeted selection; the pi function falls between 0 to 1, while the µ function ranges
from −3 to 3.
by Var(Z | x) = Var(ν). Specifically, note the identity
(9) E(Y | x, Z) = (τ + b)Z + (β − bγ)tx− b(Z − γtx) = τˆZ + βˆtx− ˆ,
which is true for any value of the scalar parameter b, the bias of τˆ . Intuitively, if neighborhoods
of βˆ = (β − bγ) have higher prior probability than β and Var(ˆ) = b2Var(ν) is small on average
relative to σ2, then the posterior distribution for τ is apt to be biased toward τˆ = τ + b.
The bias will be large precisely when confounding is strong and the selection is targeted: For non-
negligible bias the term b2Var(ν) is smallest when Var(ν) is small, that is, when selection (hence,
confounding) is strong. For priors on β that are centered at zero —which is overwhelmingly the
default — the (β− bγ) term can be made most favorable with respect to the prior when the vector
β and γ have the same direction, which corresponds to perfectly targeted selection.
Targeted selection and RIC in nonlinear models. To investigate RIC in more complex regression
settings, we start with a simple 2-d example characterized by targeted selection:
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Table 1
The standard BART prior exhibits substantial bias in estimating the treatment effect, poor coverage of 95% posterior
(quantile-based) credible intervals, and high root mean squared error (rmse). A modified BART prior (denoted BCF)
allows splits in an estimated propensity score; it performs markedly better on all three metrics.
Prior bias coverage rmse
BART 0.27 65% 0.31
BCF 0.14 95% 0.21
Example 1: d = 2, n = 250, homogeneous effects. Consider the following simple data generating
process:
Yi = µ(x1, x2)− τZi + i,
E(Yi | xi1, xi2, Zi = 1) = µ(x1, x2),
E(Zi | xi1, xi2) = pi(µ(xi1, xi2), xi1, xi2),
= 0.8Φ
(
µ(xi1, xi2)
0.1(2− xi1 − xi2) + 0.25
)
+ 0.025(xi1 + xi2) + 0.05
i
iid∼N(0, 1), xi1, xi2 iid∼Uniform(0, 1).
(10)
Suppose that in (10) Y is a continuous biometric measure of heart distress, Z is an indicator
for having received a heart medication, and x1 and x2 are systolic and diastolic blood pressure (in
standardized units), respectively. Suppose that it is known that the difference between these two
measurements is prognostic of high distress levels, with positive levels of x1 − x2 being a critical
threshold. At the same time, suppose that prescribers are targeting the drug towards patients with
high levels of diagnostic markers, so the probability of receiving the drug is an increasing function
in µ. Figure 3 shows pi as a function of x1 and x2; figure 2 shows the relationship between µ and pi
for various values of x˜ = x1 + x2.
We simulated 200 datasets of size n = 250 according to this data generating process with τ =
−1. With only a few covariates, low noise, and a relatively large sample size, we might expect
most methods to perform well here. Table 1 shows that standard, unmodified BART exhibits high
bias and root mean squared error (RMSE) as well as poor coverage of 95% credible intervals.
Our proposed fix (detailed below) improves on both estimation error and coverage, primarily by
including an estimate of pi as a covariate.
What explains BART’s relatively poor performance on this DGP? First, strong confounding
and targeted selection implies that µ is approximately a monotone function of pi alone (Figure 4).
However, pi (and hence µ) is difficult to learn via regression trees — it takes many axis-aligned splits
to approximate the “shelf” across the diagonal (see Figure 5), and the BART prior specifically
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Fig 4. This scatterplot depicts µ(x) = E(Y | Z = 0, x) and pi(x) = E(Z | x) for a realization from the data generating
process from the above example. It shows clear evidence of targeted selection. Such plots, based on estimates (µˆ, pˆi)
can provide evidence of (strong) targeted selection in empirical data.
penalizes this kind of complexity. At the same time, due to the strong confounding in this example
a single split in Z can stand in for many splits on x1 and x2 that would be required to approximate
µ(x). These simpler structures are favored by the BART prior, leading to RIC.
Before discussing how we reduce RIC, we note that this example is somewhat stylized in that
we designed it specifically to be difficult to learn for tree-based models. Other models might suffer
less from RIC on this particular example. However, any informative, sparse, or nonparametric prior
distribution – any method that imposes meaningful regularization – is susceptible to similar effects,
as they prioritize some data-generating processes at the expense of others. Absent prior knowledge
of the form of the treatment assignment and outcome models, it is impossible to know a prior
whether RIC will be an issue. Fortunately it is relatively straightforward to minimize the risk of
bias due to RIC.
4.3. Mitigating RIC with covariate-dependent priors. Finally, we arrive at the role of the propen-
sity score in a regularized regression context. The potential for RIC is strongest when µ(x) is exactly
or approximately a function of pi(x) and when the composition of the two has relatively low prior
support. This can lead the model to misattribute the variability of µ, in the direction of pi, to Z.
A natural solution to this problem would be to include pi(x) as a covariate, so that it is penalized
12
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Fig 5. Many axis-aligned splits are required to approximate a step function (or near-step function) along the diagonal
in the outcome model, as in Fig. 3 (right panel). Since these two regions correspond also to disparate rates of treatment,
tree-based regularized regression is apt to overstate the treatment effect.
equitably with changes in the treatment variable Z. That is, when evaluating candidate functions
for our estimate of E(Y | x, z) we want representations involving pi(x) to be regularized/penalized
the same as representations involving z. Of course pi is unknown and must be estimated, but this
is a straightforward regression problem.
Mitigating RIC in the linear model. Given an estimate of the propensity function zˆi ≈ γtxi, we
consider the over-complete regression that includes as regressors both z and zˆ. Our design matrix
becomes
X˜ =
(
z zˆ X
)
.
This covariate matrix is degenerate because zˆ is in the column span of X by construction. In a
regularized regression proglem this degeneracy is no obstacle. Applying the expression for the bias
from above, with a flat prior over the coefficient associated with zˆ, yields
bias(τˆrr) = −
{
(z˜tz˜)−1z˜tX
}
1
(I + Xt(X− Xˆz))−1β = 0,
where z˜ = (z zˆ) and
{
(z˜tz˜)−1z˜tX
}
1
denotes the top row of
{
(z˜tz˜)−1z˜tX
}
, which corresponds to
the regression coefficient associated with z in the two variable regression predicting Xj given z˜.
Because zˆ captures the observed association between z and x, z is conditionally independent of x
given zˆ, from which we conclude that these regression coefficients will be zero. See Yang, Cheng
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and Dunson (2015) for a similar de-biasing strategy in a partially linear semiparametric context.
Mitigating RIC in nonlinear models. The same strategy also proves effective in the nonlinear
setting — simply by including an estimate of the propensity score as a covariate in the BART
model, the RIC effect is dramatically mitigated, as can be seen in the second row of Table 1.
From a Bayesian perspective, this is simply a judicious variable transformation since our regression
model is specified conditional on both Z and x — we are not obliged to consider uncertainty in
our estimate of pi to obtain valid posterior inference. We obtain another example of a covariate
dependent prior, similar to Zellner’s g-prior (albeit motivated by very different considerations). See
section 8 for additional discussion of this point.
To summarize, although it has long been known that the propensity score is a sufficient dimension
reduction for estimation of the ATE – and that combining estimates of the response surface and
propensity score can improve estimation of average treatment effects (Bang and Robins, 2005), we
find that incorporating an estimate of the propensity score into estimation of the response surface
can improve estimation of average treatment effects in finite samples. As we will demonstrate in
Section 6, these benefits also accrue when estimating (heterogeneous) conditional average treatment
effects. Estimating heterogenous effects also calls for careful consideration of regularization applied
to the treatment effect function, which we consider in the next section.
5. Regularization for heterogeneous treatment effects: Bayesian causal forests. In
much the same way that a direct BART prior on f does not allow careful handling of confounding,
it also does not allow separate control over the discovery of heterogeneous effects because there is no
explicit control over how f varies in Z. Our solution to this problem is a simple re-parametrization
that avoids the indirect specification of the prior over the treatment effects:
(11) f(xi, zi) = µ(xi) + τ(xi)zi.
This model can be thought of as a linear regression in z with covariate-dependent functions for both
the slope and the intercept. Writing the model this way sacrifices nothing in terms of expressiveness,
but permits independent priors to be placed on τ , which is precisely the treatment effect:
(12) E(Yi | xi, Zi = 1)− E(Yi | xi, Zi = 0) = {µ(xi) + τ(xi)} − µ(xi) = τ(xi).
Under this model µ(x) = E(Y | Z = 0, X = x) is a prognostic score in the sense of ?, another
interpretable quantity, to which we apply an prior distribution independent of τ (as detailed below).
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Based on the observations of the previous section, we further propose specifying the model as
(13) f(xi, zi) = µ(xi, pˆii) + τ(xi)zi,
where pˆii is an estimate of the propensity score.
While we will use variants of BART priors for µ and τ (see section 5.2), this parameterization
has many advantages in general, regardless of the specific priors. The most obvious advantage is
that the treatment effect is an explicit parameter of the model, τ(x), and as a result we can specify
an appropriate prior on it directly. Before turning to the details of our model specification, we first
contrast this parameterization with two common alternatives.
5.1. Parameterizing regression models of heterogeneous effects. There are two common modeling
strategies for estimating heterogeneous effects. The first we discussed above: treat z as “just another
covariate” and specify a prior on f(xi, zi), e.g. as in Hill (2011). The second is to fit entirely separate
models to the treatment and control data: (Y | Z = z, x) ∼ N(fz(xi), σ2z) with independent priors
over the parameters in the z = 0 and z = 1 models. In this section we argue that neither approach
is satisfactory and propose the model in (13) as a reasonable interpolation between the two. (See
Ku¨nzel et al. (2017) for a related discussion comparing these two approaches in a non-model-based
setting.)
It is instructive to consider (11) as a nonlinear regression analogue of the common strategy
of parametrizing contrasts (differences) and aggregates (sums) rather than group-specific location
parameters. Specifically, consider a two-group difference-in-means problem:
Yi1
iid∼N(µ1, σ2)
Yj2
iid∼N(µ2, σ2).
(14)
Although the above parameterization is intuitive, if the estimand of interest is µ1−µ2, the implied
prior over this quantity has variance strictly greater than the variances over µ1 or µ2 individually.
This is plainly nonsensical if the analyst has no subject matter knowledge regarding the individual
levels of the groups, but has strong prior knowledge that µ1 ≈ µ2. This is common in a causal
inference setting: If the data come from a randomized experiement where Y1 constitutes a control
sample and Y2 a treated sample, then subject matter considerations will typically limit the plausible
range of treatment effects µ1 − µ2.
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The appropriate way to incorporate that kind of knowledge is simply to reparametrize as
Yi1
iid∼N(µ+ τ, σ2)
Yj2
iid∼N(µ, σ2)
(15)
whereupon the estimand of interest becomes τ , which can be given an informative prior centered at
zero with an appropriate variance. Meanwhile, µ can be given a very vague (perhaps even improper)
prior.
While the nonlinear modeling context is more complex, the considerations are the same: our
goal is simultaneously to let µ(x) be flexibly learned (to adequately deconfound and obtain more
precise inference), while appropriately regularizing τ(x), which we expect, a priori, to be rela-
tively small in magnitude and “simple” (minimal heterogeneity). Neither of the two more common
parametrizations permit this: Independent estimation of f0(x) and f1(x) implies a highly vague prior
on τ(x) = f1(x)−f0(x); i.e. a Gaussian process prior on each would imply a twice-as-variable Gaus-
sian process prior on the difference, as in the simple example above. Estimation based on the single
response surface f(x, z) often does not allow direct point-wise control of τ(x) = f(x, 1)− f(x, 0) at
all. In particular, with a BART prior on f the induced prior on τ depends on incidental features
of the data such as the size and distribution of the covariate vector x.
5.2. Prior specfication. With the model parameterized as in (13), we can specify different BART
priors on µ and τ . For µ we use the default suggestions in (Chipman, George and McCulloch, 2010)
(200 trees, β = 2, η = 0.95), except that we place a half-Cauchy prior over the scale of the
leaf parameters with prior median equal to twice the marginal standard deviation of Y (Gelman
et al., 2006; Polson et al., 2012). We find that inference over τ is typically insensitive to reasonable
deviations from these settings, so long as the prior is not so strong that deconfounding does not
take place.
For τ , we prefer stronger regularization. First, we use fewer trees (50 versus 200), as we generally
believe that patterns of treatment effect heterogeneity are relatively simple. Second, we set the
depth penalty β = 3 and splitting probability η = 0.25 (instead of β = 2 and η = 0.95) to shrink
more strongly toward homogenous effects (the extreme case where none of the trees split at all
corresponds to purely homogenous effects). Finally, we replace the half-Cauchy prior over the scale
of τ with a half Normal prior, pegging the prior median to the marginal standard deviation of Y .
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6. Empirical evaluations. In this section, we provide a more extensive look at how BCF
compares to various alternatives. In Section 6.1 we compare BCF, generalized random forests
(Athey, Tibshirani and Wager, 2016), and a linear model with all three-way interactions as plausible
methods for estimating heterogeneous treatment effects with measures of uncertainty. We also
consider three specifications of BART: the standard response surface BART that considers the
treatment variable as “just another covariate”, one where separate BART models are fit to the
treatment and control arms of the data, and one where an estimate of the propensity score is
included as a predictor. In Section 6.2 we report on the results of two separate data analysis
challenges, where the entire community was invited to submit methods for evaluation on larger
synthetic datasets with heterogeneous treatment effects. In both simulation settings we find that
BCF performs well under a wide range of scenarios.
In all cases the estimands of interest are either conditional average treatment effects for individual
i accounting for all the variables, estimated by the posterior mean treatment effect τˆ(xi), or sample
subgroup average treatment effects estimated by
∑
i∈S τˆ(xi), where S is the subgroup of interest.
Credible intervals are computed from MCMC output.
6.1. Simulation studies. We evaluated three variants of BART, the causal random forest model
of Athey, Tibshirani and Wager (2016), and a regularized linear regression with up to three way in-
teractions. We consider eight distinct, but closely related, data generating processes, corresponding
to the various combinations of toggling three two-level settings: homogeneous versus heterogeneous
treatment effects, a linear versus nonlinear conditional expectation function, and two different sam-
ple sizes (n = 250 and n = 500). Five variables comprise x; the first three are continuous, drawn as
standard normal random variables, the fourth is a dichotomous variable and the fifth is unordered
categorical, taking three levels (denoted 1,2,3). The treatment effect is either
τ(x) =
 3, homogeneous1 + 2x2x5, heterogeneous,
the prognostic function is either
µ(x) =
 1 + g(x4) + x1x3, linear−6 + g(x4) + 6|x3 − 1|, nonlinear,
where g(1) = 2, g(2) = −1 and g(3) = −4, and the propensity function is
pi(xi) = 0.8Φ(3µ(xi)/s− 0.5x1) + 0.05 + ui/10
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where s is the standard deviation of µ taken over the observed sample and ui ∼ Uniform(0, 1).
To evaluate each method we consider three criteria, applied to two different estimands. First,
we consider how each method does at estimating the (sample) average treatment effect (ATE)
according to root mean square error, coverage, and average interval length. Then, we consider
the same criteria, except applied to estimates of the conditional average treatment effect (CATE),
averaged over the sample. Results are based on 200 independent replications for each DGP. Results
are reported in Tables 2 (for the linear DGP) and 3 (for the nonlinear DGP). The important trends
are as follows:
• BCF or ps-BART benefit dramatically by explicitly protecting against RIC;
• BART-(f0, f1) and causal random forests both exhibit subpar performance in this simulation;
• all methods improve with a larger sample;
• BCF priors are especially helpful at the smaller sample size (when estimation is more difficult);
• the linear model dominates when correct, but fares extremely poorly when wrong;
• BCF’s improvements over ps-BART are more pronounced in the nonlinear DGP;
• BCF’s average interval length is notably smaller than the ps-BART interval, usually (but not
always) with comparable coverage.
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Table 2
Simulation study results when the true DGP is a linear model with third order interactions. Root mean square
estimation error (rmse), coverage (cover) and average interval length (len) are reported for both the average
treatment effect (ATE) estimates and the conditional average treatment effect estimates (CATE).
Homogeneous effect Heterogeneous effects
n Method ATE CATE ATE CATE
rmse cover len rmse cover len rmse cover len rmse cover len
250
BCF 0.21 0.92 0.91 0.48 0.96 2.0 0.27 0.84 0.99 1.09 0.91 3.3
ps-BART 0.22 0.94 0.97 0.44 0.99 2.3 0.31 0.90 1.13 1.30 0.89 3.5
BART 0.34 0.73 0.94 0.54 0.95 2.3 0.45 0.65 1.10 1.36 0.87 3.4
BART (f0, f1) 0.56 0.41 0.99 0.92 0.93 3.4 0.61 0.44 1.14 1.47 0.90 4.5
Causal RF 0.34 0.73 0.98 0.47 0.84 1.3 0.49 0.68 1.25 1.58 0.68 2.4
LM + HS 0.14 0.96 0.83 0.26 0.99 1.7 0.17 0.94 0.89 0.33 0.99 1.9
500
BCF 0.16 0.88 0.60 0.38 0.95 1.4 0.16 0.90 0.64 0.79 0.89 2.4
ps-BART 0.18 0.86 0.63 0.35 0.99 1.8 0.16 0.90 0.69 0.86 0.95 2.8
BART 0.27 0.61 0.61 0.42 0.95 1.8 0.25 0.76 0.67 0.88 0.94 2.8
BART (f0, f1) 0.47 0.21 0.66 0.80 0.93 3.1 0.42 0.42 0.75 1.16 0.92 3.9
Causal RF 0.36 0.47 0.69 0.52 0.75 1.2 0.40 0.59 0.88 1.30 0.71 2.1
LM + HS 0.11 0.96 0.54 0.18 0.99 1.0 0.12 0.93 0.59 0.22 0.98 1.2
Table 3
Simulation study results when the true DGP is nonlinear. Root mean square estimation error (rmse), coverage
(cover) and average interval length (len) are reported for both the average treatment effect (ATE) estimates and the
conditional average treatment effect estimates (CATE).
Homogeneous effect Heterogeneous effects
n Method ATE CATE ATE CATE
rmse cover len rmse cover len rmse cover len rmse cover len
250
BCF 0.26 0.945 1.3 0.63 0.94 2.5 0.30 0.930 1.4 1.3 0.93 4.5
ps-BART 0.54 0.780 1.6 1.00 0.96 4.3 0.56 0.805 1.7 1.7 0.91 5.4
BART 0.84 0.425 1.5 1.20 0.90 4.1 0.84 0.430 1.6 1.8 0.87 5.2
BART (f0, f1) 1.48 0.035 1.5 2.42 0.80 6.4 1.44 0.085 1.6 2.6 0.83 7.1
Causal RF 0.81 0.425 1.5 0.84 0.70 2.0 1.10 0.305 1.8 1.8 0.66 3.4
LM + HS 1.77 0.015 1.8 2.13 0.54 4.4 1.65 0.085 1.9 2.2 0.62 4.8
500
BCF 0.20 0.945 0.97 0.47 0.94 1.9 0.23 0.910 0.97 1.0 0.92 3.4
ps-BART 0.24 0.910 1.07 0.62 0.99 3.3 0.26 0.890 1.06 1.1 0.95 4.1
BART 0.31 0.790 1.00 0.63 0.98 3.0 0.33 0.760 1.00 1.1 0.94 3.9
BART (f0, f1) 1.11 0.035 1.18 2.11 0.81 5.8 1.09 0.065 1.17 2.3 0.82 6.2
Causal RF 0.39 0.650 1.00 0.54 0.87 1.7 0.59 0.515 1.18 1.5 0.73 2.8
LM + HS 1.76 0.005 1.34 2.19 0.40 3.5 1.71 0.000 1.34 2.2 0.45 3.7
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6.2. Atlantic causal inference conference data analysis challenges. The Atlantic Causal Infer-
ence Conference (ACIC) has featured a data analysis challenge since 2016. Participants are given
a large number of synthetic datasets and invited to submit their estimates of treatment effects
along with confidence or credible intervals where available. Specifically, participants were asked to
produce estimates and uncertainty intervals for the sample average treatment effect on the treated,
as well as conditional average treatment effects for each unit. Methods were evaluated based on a
range of criteria including estimation error and coverage of uncertainty intervals. The datasets and
ground truths are publicly available, so while BCF was not entered into either the 2016 or 2017
competitions we can benchmark its performance against a suite of methods that we did not choose,
design, or implement.
6.2.1. ACIC 2016 competition. The 2016 contest design, submitted methods, and results are
summarized in Dorie et al. (2017). Based on an early draft of our manuscript Dorie et al. (2017) also
evaluated a version of BART that included an estimate of the propensity score, which was one of the
top methods on bias and RMSE for estimating the sample ATT. BART with the propensity score
outperformed BART without the propensity score on bias, RMSE, and coverage for the SATT, and
was a leading method overall.
Therefore, rather than include results for all 30 methods here we simply include BART and ps-
BART as leading contenders for estimating heterogeneous treatment effects in this setting. Using
the publicly-available competition datasets (Dorie and Hill, 2017) we implemented two additional
methods: BCF and causal random forests as implemented in the R package grf (Athey, Tibshirani
and Wager, 2016), using 4,000 trees to obtain confidence intervals for conditional average treatment
effects and a doubly robust estimator for the SATT (as suggested in the package documentation).
Table 4 collects the results of our methods (ps-BART and BCF) as well as BART and causal
random forests. Causal random forests performed notably worse than BART-based methods on
every metric. BCF performed best in terms of estimation error for CATE and SATT, as measured
by bias and absolute bias. While the differences in the various metrics are relatively small compared
to their standard deviation across the 7,700 simulated datasets, nearly all the pairwise differences
between BCF and the other methods are statistically significant as measured by a permutation
test (Table 5). The sole exception is the test for a difference in bias between ps-BART and BCF,
suggesting the presence of RIC in at least some of the simulated datasets. This is especially notable
since the datasets were not intentionally simulated to include targeted selection.
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Dorie et al. (2017) note that all submitted methods were “somewhat disappointing” in inference
for the SATT (i.e., few methods had coverage near the nominal rate with reasonably sized intervals).
However, ps-BART did relatively well, 88% coverage of a 95% credible interval and one of the
smallest interval lengths. ps-BART had slightly better coverage than BCF (88% versus 82%), with
an average interval length that was 45% larger than BCF. Vanilla BART and BCF had similar
coverage rates, but BART’s interval length was about 55% larger than BCF. Dorie et al. (2017)
found that TMLE-based adjustments could improve the coverage of BART-based estimates of the
SATT at significant computational cost; we expect that similar benefits would accrue using BCF
with a TMLE adjustment, but obtaining valid confidence intervals for SATT is not our focus so we
did not pursue this further.
Table 4
Abbreviated ACIC 2016 contest results. Coverage and average interval length are reported for nominal 95%
uncertainty intervals. Bias and |Bias| are average bias and average absolute bias, respectively, over the. PEHE is the
average precision in estimating heterogeneous treatment effects (the average root mean squared error of CATE
estimates for each unit in a dataset) (Hill, 2011).
Coverage Interval Length Bias (SD) |Bias| (SD) PEHE (SD)
BCF 0.82 0.026 -0.0009 (0.01) 0.008 0.010 0.33 0.18
ps-BART 0.88 0.038 -0.0011 (0.01) 0.010 0.011 0.34 0.16
BART 0.81 0.040 -0.0016 (0.02) 0.012 0.013 0.36 0.19
Causal RF 0.58 0.055 -0.0155 (0.04) 0.029 0.027 0.45 0.21
Table 5
Tests and estimates for differences between BCF and other methods in the ACIC 2016 competition. The p-values are
from bootstrapp permutation tests with 100,000 replicates.
Diff Bias p Diff |Bias| p Diff PEHE p
ps-BART -0.00020 0.146 0.0011 < 1e−4 0.010 < 1e−4
BART -0.00070 < 1e−4 0.0031 < 1e−4 0.037 < 1e−4
Causal RF -0.01453 < 1e−4 0.0204 < 1e−4 0.125 < 1e−4
6.2.2. ACIC 2017 competition. The ACIC 2017 competition was designed to have average treat-
ment effects that were smaller, with heterogenous treatment effects that were less variable, relative
to the 2016 datasets. Arguably, the 2016 competition included many datasets with unrealistically
large average treatment effects and similarly unrealistic degrees of heterogeneity1. Additionally, the
2017 competition explicitly incorporated targeted selection (unlike the 2016 datasets). The ACIC
1Across the 2016 competition datasets, the interquartile range of the SATT was 0.57 to 0.79 in standard deviations
of Y , with a median value of 0.68. The standard deviation of the conditional average treatment effects for the sample
units had an interquartile range of 0.24 to 0.93, again in units of standard deviations of Y . A significant fraction of
the variability in Y was explained by heterogeneous treatment effects in a large number of the simulated datasets.
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Fig 6. Each data point represents one method. ps-BART (psB, in orange) was submitted by a group independent of
the authors based on a draft of this manuscript. TL (purple) is a TMLE-based submission that performed will for
estimating SATT, but did not furnish estimates of conditional average treatment effects. BCF (green) and causal
random forests (CRF, blue) were not part of the original contest. For descriptions of the other methods refer to Hahn,
Dorie and Murray (2018).
2017 competition design and results are summarized completely in Hahn, Dorie and Murray (2018);
here we report selected results for the datasets with independent additive errors.
Figure 6.2.2 contains the results of the 2017 competition. The patterns here are largely similar
to the 2016 competition, despite some stark differences in the generation of synthetic datasets.
ps-BART and BCF have the lowest estimation error for CATE and SATE. The closest competitor
on estimation error was a TMLE-based approach. We also see that ps-BART edges BCF slightly
in terms of coverage once again, although BCF has much shorter intervals. Causal random forests
does not perform well, with coverage for SATT and CATE far below the nominal rate.
7. Application: The effect of smoking on medical expenditures.
7.1. Background and data. As an empirical demonstration of the Bayesian causal forest model,
we consider the question of how smoking affects medical expenditures. This question is of interest
as it relates to lawsuits against the tobacco industry. The lack of experimental data speaking to this
question motivates the reliance on observational data. This question has been studied in several
previous papers; see Zeger et al. (2000) and references therein. Here, we follow Imai and Van Dyk
(2004) in analyzing data extracted from the 1987 National Medical Expenditure Survey (NMES)
by Johnson et al. (2003). The NMES records many subject-level covariates and boasts third-party-
verified medical expenses. Specifically, our regression includes the following ten patient attributes:
• age: age in years at the time of the survey
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• smoke age: age in years when the individual started smoking
• gender: male or female
• race: other, black or white
• marriage status: married, widowed, divorced, separated, never married
• education level: college graduate, some college, high school graduate, other
• census region: geographic location, Northeast, Midwest, South, West
• poverty status: poor, near poor, low income, middle income, high income
• seat belt: does patient regularly use a seat belt when in a car
• years quit: how many years since the individual quit smoking.
The response variable is the natural logarithm of annual medical expenditures, which makes the
normality of the errors more plausible. Under this transformation, the treatment effect corresponds
to a multiplicative effect on medical expenditure. Following Imai and Van Dyk (2004), we restrict our
analysis to smokers who had non-zero medical expenditure. Our treatment variable is an indicator
of heavy lifetime smoking, which we define to be greater than 17 pack-years, the equivalent of
17 years of pack-a-day smoking. See again Imai and Van Dyk (2004) for more discussion of this
variable. We scrutinize the overlap assumption and exclude individuals younger than 28 on the
grounds that it is improbable for someone that young to have achieved this level of exposure. After
making these restrictions, our sample consists of n = 6, 798 individuals.
7.2. Results. Here, we highlight the differences that arise when analyzing this data using stan-
dard BART versus using BCF. First, the estimated expected responses from the two models have
correlation of 0.98, so that the two models concur on the nonlinear prediction problem. This suggests
that, as was intended, BCF will inherit BART’s outstanding predictive capabilities. By contrast,
the estimated individual treatment effects are only correlated 0.70. The most notable differences
between these CATE estimates is that the BCF estimates exhibit a strong trend in the age variable,
as shown in Figure 7.2; the BCF estimates suggest that smoking has an pronounced impact on the
health expenditures of younger people.
Despite a wider range of values in the CATE estimates (due largely to the inferred trend in
the age variable), the ATE estimate of BCF is notably lower than that of BART, the posterior
95% credible intervals being translated by 0.05, (0.00, 0.20) for BCF vs (0.05, 0.25) for BART. The
higher estimate of BART is possibly a result of RIC. Figure 7.2 shows a LOWESS trend between
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the estimated propensity and prognostic scores (from BCF); the monotone trend is suggestive
of targeted selection (high medical expenses are predictive of heavy smoking) and hints at the
possibility of RIC-type inflation of the BART ATE estimate (compare to Figures 2 and 4).
Although the vast majority of individual treatment effect estimates are statistically uncertain,
as reflected in posterior 95% credible intervals that contain zero (Figure 7.2), the evidence for
subgroup heterogeneity is relatively strong, as uncovered by the following posterior exploration
strategy. First, we grow a parsimonious regression tree to the point estimates of the individual
treatment effects (using the rpart package in R); see the left panel of Figure 7.2. Then, based on
the candidate subgroups revealed by the regression summary tree, we plot a posterior histogram of
the difference between any two covariate-defined subgroups. The right panel of Figure 7.2 shows the
posterior distribution of the difference between men younger than 46 and women over 66; virtually
all of the posterior mass is above zero, suggesting that the treatment effect of heavy smoking is
discernibly different for these two groups, with young men having a substantially higher estimated
subgroup ATE. This approach, although somewhat informal, is a method of exploring the posterior
distribution and, as such, any resulting summaries are still valid Bayesian inferences. Moreover,
such Bayesian “fit-the-fit” posterior summarization strategies can be formalized from a decision
theoretic perspective (Sivaganesan, Mu¨ller and Huang, 2017; Hahn and Carvalho, 2015); we do not
explore this possibility further here.
From the above we conclude that how a model treats the age variable would seem to have an
outsized impact on the way that predictive patterns are decomposed into treatment effect estimates
based on this data, as age plausibly has prognostic, propensity and moderating roles simultaneously.
Although it is difficult to trace the exact mechanism by which it happens, the BART model clearly
de-emphasizes the moderating role, whereas the BCF model is designed specifically to capture such
trends. Possible explanations for the age heterogeneity could be a mixed additive-multiplicative
effect combined with higher baseline expenditures for older individuals or possibly survivor bias (as
also mentioned in Imai and Van Dyk (2004)), but further speculation is beyond the scope of this
analysis.
8. Discussion. We have demonstrated the utility of our new model for the estimation of
conditional average treatment effects. We conclude by reviewing the contributions made here and
positioning them in the existing literature.
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Fig 7. Each gray dot depicts the estimated propensity and prognostic scores for an individual. The solid bold line
depicts a LOESS trend fit to these points; the monotonicity is suggestive of targeted selection. Compare to Figures 2
and 4.
Fig 8. Point estimates of individual treatment effects are shown in black. The smooth line depicts the estimates from
BCF, which are ordered from smallest to largest. The unordered points represent the corresponding ITE estimates
from BART. Note that the BART estimates seem to be higher, on average, than the BCF estimates. The upper and
lower gray dots correspond to the posterior 95% credible interval end points associated with the BCF estimates; most
ITE intervals contain zero, especially those with smaller (even negative) point estimates.
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Fig 9. Each point depicts the estimated treatment effect for an individual. The BCF model (left panel) detects pro-
nounced heterogeneity moderated by the age variable, whereas BART (right panel) does not.
Fig 10. Left panel: a summarizing regression tree fit to posterior point estimates of individual treatment effects.
The top number in each box is the average subgroup treatment effect in that partition of the population, the lower
number shows the percentage of the total sample constituting that subgroup. Age and gender are flagged as important
moderating variables. Right panel: based on the tree in the left panel, we consider the difference in treatment effects
between men younger than 46 and women older than 66; a posterior histogram of this difference shows that nearly
all of the posterior mass is above zero, indicating that these two subgroups are discernibly different, with young men
having substantially higher subgroup average treatment effect.
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8.1. Zellner priors for non- and semiparametric Bayesian causal inference. In Section 4 we
showed that the current gold standard in nonparametric Bayesian regression models for causal
inference (BART) is susceptible to regression induced confounding as described by Hahn et al.
(2016). The solution we propose is to include an estimate of the propensity score as a covariate in
the outcome model. This induces a prior distribution that treats Zi and pˆii equitably, discouraging
the outcome model from erroneously attributing the effect of confounders to the treatment variable.
Here we justify and collect arguments in favor of this approach. We discuss an argument against,
namely that it does not incorporate uncertainty in the propensity score, in a later subsection.
Conditioning on an estimate of the propensity score is readily justified: Because our regression
model is conditional on Z and X, it is perfectly legitimate to condition our prior on them as well.
This approach is widely used in linear regression, the most common example being Zellner’s g-prior
(Zellner, 1986) which parametrizes the prior covariance of a vector of regression coefficients in terms
of a plug-in estimate of the predictor variables’ covariance matrix. Nodding to this heritage, we
propose to call general predictor-dependent priors “Zellner priors”.
In the Bayesian causal forest model, we specify a prior over f by applying an independent BART
prior that includes pˆi(xi) as one of its splitting dimensions. That is, because pˆi(xi) is a fixed function
of xi, f is still a function f : (X ,Z) 7→ R; the inclusion of pˆi(xi) among the splitting dimensions does
not materially change the support of the prior, but it does alter which functions are deemed more
likely. Therefore, although writing f(xi, zi, pˆi(xi)) is suggestive of how the prior is implemented in
practice, we prefer notation such as
Yi = f(xi, zi) + i, i
iid∼N(0, σ2),
f ∼ BART(X, Z, pˆi),
(16)
where pˆi is itself a function of (X, Z). Viewing BART as a prior in this way highlights the fact that
various transformations of the data could be computed beforehand, prior to fitting the data with
the default BART priors; the choice of transformations will control the nature of the regularization
that is imposed. In conventional predictive modeling there is often no particular knowledge of which
transformations of the covariates might be helpful. However, in the treatment effect context the
propensity score is a natural and, in fact, critical choice.
8.2. Why not use only the propensity score? vs. Why use the propensity score at all?. It has
long been recognized that regression on the propensity score is a useful dimension reduction tactic
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(Rosenbaum and Rubin, 1983). For the purpose of estimating average treatment effects, a regression
model on the one-dimensional propensity score is sufficient for the task, allowing one to side-step
estimating high dimensional nuisance parameters. In our notation, if pi is assumed known, then one
need only infer f(pi). That said, there are several reasons one should include the control vector xi
in its entirety (in addition to the propensity score).
The first reason is pragmatic: If one wants to identify heterogeneous effects, one needs to include
any potential effect moderating variables anyway, precluding any dimension reduction at the outset.
Second, if we are to take a conditionally-iid Bayesian regression approach to inference and we
do not in fact believe the response to depend on X strictly through the propensity score, we
simply must include the covariates themselves and model the conditional distribution p(Y | Z,X)
(otherwise the error distribution is highly dependent, integrated across X). The justification for
making inference about average treatment effects using regression or stratification on the propensity
score alone is entirely frequentist; this approach is not without its merits, and we do not intend to
argue frequency calibration is not desirable, but a fully Bayesian approach has its own appeal.
Third, if our propensity score model is inadequate (misspecified or otherwise poorly estimated),
including the full predictor vector allows for the possibility that the response surface model remains
correctly specified.
The converse question, Why bother with the propensity score if one is doing a high dimensional
regression anyway?, has been answered in the main body of this paper. Incorporating the propensity
score (or another balancing score) yields a prior that can more readily adapt to complex patterns
of confounding. In fact, in the context of response surface modeling for causal effects, failing to
include an estimate of the propensity score (or another balancing score) can lead to additional bias
in treatment effect estimates, as shown by the simple, low-dimensional example in Section 4.
8.3. Why not joint response-treatment modeling and what about uncertainty in the propensity
score?. Using a presumptive model for Z to obtain pˆi invites the suggestion of fitting a joint
model for (Y,Z). Indeed, this is the approach taken in Hahn et al. (2016) as well as earlier papers,
including Rosenbaum and Rubin (1983), Robins, Mark and Newey (1992), McCandless, Gustafson
and Austin (2009), Wang, Parmigiani and Dominici (2012), and Zigler and Dominici (2014). While
this approach is certainly reasonable, the Zellner prior approach would seem to afford all the same
benefits while avoiding the distorted inferences that would result from a joint model if the propensity
score model is misspecified (Zigler and Dominici, 2014).
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One might argue that our Zellner prior approach gives under-dispersed posterior inference in
the sense that it fails to account for the fact that pˆi is simply a point estimate (and perhaps a
bad one). However, this objection is somewhat misguided. First, as discussed elsewhere (e.g. Hill
(2011)), inference on individual or subgroup treatment effects follows directly from the conditional
distribution (Y | Z,X). To continue our analogy with the more familiar Zellner g-prior, to model
(Y | Z,X) we are no more obligated to consider uncertainty in pˆi than we are to consider uncertainty
in (X′X)−1 when using a g-prior for on the coefficients of a linear model. Second, pˆi appears in the
model along with the full predictor vector x: it is provided as a hint, not as a certainty, and this
model is at least as capable of estimating a complex response surface as the corresponding model
without pˆi, and the cost incurred by the addition of a one additional “covariate” can be more than
offset by the bias reduction in the estimation of treatment effects.
On the other hand, we readily acknowledge that one might be interested in what inferences would
obtain if we used different pˆi estimates. One might consider fitting a series of BCF models with
different estimates of pˆi, perhaps from alternative models or other procedures. This is a natural form
of sensitivity analysis in light of the fact that the adjustments proposed in this paper only work
if pˆi accurately approximates pi. However, it is worth noting that the available (z, x) data speak to
this question: a host of empirically proven prediction methods (i.e. neural networks, support vector
machines, random forests, boosting, or any ensemble method) can be used to construct candidate
pˆi and cross-validation may be used to gauge their accuracy. Only if a “tie” in generalization error
(predicting Z) is encountered must one turn to sensitivity analysis.
8.4. Connections to doubly robust estimation. Our combination of propensity score estimation
and outcome modeling is superficially reminiscent of doubly robust estimation (Bang and Robins,
2005), where propensity score and outcome regression models are combined to yield consistent
estimates of finite dimensional treatment effects, provided at least one model is correctly specified.
We do not claim our approach is doubly robust, however, and in all of our examples above we use
the natural Bayesian estimates of (conditional) average treatment effects rather than doubly robust
versions.
The motivation behind our approach is in fact quite different than that behind doubly robust
estimation: RIC is fundamentally a finite sample phenomenon, and including the estimated propen-
sity score is an effort to improve the finite sample performance of the estimated outcome regression
model. The two approaches are complementary – if the outcome regression is more accurate in finite
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samples, similar benefits should accrue to a doubly robust estimator computed from the outcome
regression estimates.
8.5. Related non-Bayesian work. The Bayesian causal forest model is a flexible semi-parametric
prediction model for estimating causal effects. Other recent work also occupies this intersection be-
tween “machine learning” and causal inference, each with a somewhat different focus. Targeted
maximum likelihood estimation (TMLE) (van der Laan, 2010a,b), double machine learning (Cher-
nozhukov et al., 2016), and generalized boosting (McCaffrey, Ridgeway and Morral, 2004; McCaffrey
et al., 2013) all focus on estimation of average treatment effects, whereas our focus is on individual
(heterogeneous, subgroup) treatment effects. Like us, Taddy et al. (2016) focuses on estimating
heterogeneous effects, but they analyze data from experiments, whereas our data are observational.
As we have discussed, this has significant implications for how we should specify prior distributions.
Other related contributions include Su et al. (2012) and Lu et al. (2017). Finally, Wager and Athey
(2015) prove theoretical results for random forest-based estimation of heterogeneous effects from
observational data. However, Wager and Athey (2015) offer little practical guidance on how to
deploy their method in practice, in particular on how much regularization to impose, even in the
newest iteration of the method as reported in Athey, Tibshirani and Wager (2016). Moreover, as we
saw in the simulation studies and the ACIC challenge results, this method offers inferior empirical
performance, a finding that is also corroborated in Wendling et al. (2018). Given this landscape,
we believe the Bayesian causal forest model presented in this paper represents a beneficial new tool
for causal inference from observational data, especially when confounding is suspected to be strong
and the general magnitude of treatment effects is thought to be relatively modest.
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